MARKET

NGEN

NGEN

Nervgen Pharma Corp
NASDAQ
1.940
-0.080
-3.96%
After Hours: 1.980 +0.04 +2.06% 19:30 09/25 EDT
OPEN
2.000
PREV CLOSE
2.020
HIGH
2.010
LOW
1.915
VOLUME
343.20K
TURNOVER
--
52 WEEK HIGH
6.30
52 WEEK LOW
1.580
MARKET CAP
208.59M
P/E (TTM)
-3.6262
1D
5D
1M
3M
1Y
5Y
1D
NervGen Pharma Flags Non-Cash Accounting Errors, Orders Restatement of 2024–2026 Results
TipRanks · 2d ago
NervGen Pharma to restate previously filed financial statements
TipRanks · 2d ago
*NervGen Pharma: Expects to File Restated Audited Financial Statements for Year Ended Dec. 31, 2025, Including Restated 2024 Comparative Figure and Adjustment to Jan. 1, 2024, Opening Balances >NGEN
Dow Jones · 2d ago
NervGen Announces It Will Restate Its Audited Annual Financial Statements For The Year Ended December 31, 2025, And Its Unaudited Interim Financial Statements For The Quarter Ended June 30, 2026
Benzinga · 2d ago
*NervGen Pharma: Restatement Expected to Reduce Previously Reported Accumulated Deficit >NGEN
Dow Jones · 2d ago
*NervGen Pharma: Restatement Expected to Reduce Previously Reported Warrant Liabilities >NGEN
Dow Jones · 2d ago
*NervGen Pharma: Restatement Expected to Reduce Previously Reported Stock-Based Compensation Expense >NGEN
Dow Jones · 2d ago
*NervGen Pharma: Adjustments Have No Effect on Cash and Cash Equivalents, Cash Runway, or Business Operations >NGEN
Dow Jones · 2d ago
More
About NGEN
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

Webull offers NervGen Pharma Corp stock information, including NASDAQ: NGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGEN stock methods without spending real money on the virtual paper trading platform.